Hyperfine Inc. Unveils 100% Sensitivity in ARIA-E Detection with Swoop® AI-Powered Portable MRI System at 2025 Alzheimer's Conference

Reuters
07-28
<a href="https://laohu8.com/S/HYPR">Hyperfine</a> Inc. Unveils 100% Sensitivity in ARIA-E Detection with Swoop® AI-Powered Portable MRI System at 2025 Alzheimer's Conference

Hyperfine Inc. has announced interim results from the CARE PMR study, which were presented at the 2025 Alzheimer's Association International Conference in Toronto, Canada. The study evaluates the efficacy of Hyperfine's Swoop® AI-Powered Portable MRI System in detecting ARIA-E in patients undergoing amyloid-targeting therapies such as Lecanemab. The Swoop® system demonstrated a 100% sensitivity rate in identifying mild to moderate ARIA-E, offering a promising solution to the logistical and financial challenges associated with conventional MRI systems. Researchers from Washington University School of Medicine in St. Louis reported findings from 31 Alzheimer's patients, who were scanned using the Swoop® system within one week of their clinical high-field MRI scans. While the ultra-low-field MRI shows potential as a triage tool, high-field MRI may still be required for comprehensive evaluations in certain cases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hyperfine Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250728550140) on July 28, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10